Israelsen M, Dahl EK, Madsen BS, Wiese S, Bendtsen F, Møller S, Fialla AD, Jensen BL, Krag A. Dobutamine reverses the cardio-suppressive effects of terlipressin without improving renal function in cirrhosis and ascites: a randomized controlled trial. Am J Physiol Gastrointest Liver Physiol 2020;318:G313-21. [PMID: 31841026 DOI: 10.1152/ajpgi.00328.2019][Cited by in Crossref: 4][Cited by in F6Publishing: 2][Article Influence: 1.3][Reference Citation Analysis]
Number
Citing Articles
1
Kulkarni AV, Arab JP, Premkumar M, Benítez C, Tirumalige Ravikumar S, Kumar P, Sharma M, Reddy DN, Simonetto DA, Rao PN. Terlipressin has stood the test of time: Clinical overview in 2020 and future perspectives. Liver Int 2020;40:2888-905. [DOI: 10.1111/liv.14703][Cited by in Crossref: 3][Cited by in F6Publishing: 1][Article Influence: 1.5][Reference Citation Analysis]